I believe you. But like I said, you're talking about 13 year old vectors. combine SERCA2a with a Brough created wild gorilla delivery system and see what happens. I think you'll see a positive response and damaged hearts will be repaired. And for us, a step closer to a 100 dollar stock.
Never heard about the PFE use of GNVC vectors for the heart. And before TNF? I know one thing, we didn't have the mountain gorilla's vector back then. We should try it again.
The partial virus Mydicar could not successfully deliver the gene that reconstitutes an enzyme responsible for heart muscle contraction. I think we know of a partial virus that might succeed in doing it!!!!!
Doesn't the human have to received a vaccine, so that when that human is bitten by a mosquito, the mosquito receives the antibodies which renders plasmodium falciparum useless/dead?
Sentiment: Strong Buy
gary, H.C. Wainwright has a 9 and Roth has an 8; that's where they get 8.50. fyi.
It's all in the numbers. Three done and we haven't heard a word about the second and third. Second cohort to start/or has started. And remember what (I think it was him) Doug Brough said: "We've also demonstrated morphological recovery of sensory cells in human explant models."
It's just a matter of time.
Sentiment: Strong Buy
Sure. It's stuck because we only know of Rob Gerk who was dosed at the U. of Kansas Hospital by Dr. Hinrich Staeker. He hinted that his balance was better, but he could not hear better. It was at the lowest dosage. Stock went up when the sensationalism of potentially restoring hearing was reported, including TV news--google and you can find it--then settled down. We've had no further news. Novartis has now--or is about to--increase the dosage. Here's hoping!
People in the first and second cohorts--let's suppose--want their hearing back but the dosage isn't enough.
Shouldn't they, if the third cohort works, get increased dosage so they can hear? Or do the first gutsy group, stay deaf? It troubles me.
Front page of the New York Times, Sunday, says he's losing his hearing. T'would be a feather in our cap if he was in the second or third cohort and could regain his hearing.
zoos7, got a source on NSCs who went to the same school as Aboody (source is a he) I'll find out what he thinks. Like the fact that they've "oned" in humans and don't have to combine Genvec's delivery with TBX02 in animals. time is money.
Patience, bio. We're now in the king of : cancer, delivering a tumor specific metabolite, SN-38, that is a thousand times more toxic to tumors than what's available. if you are calm, cool, collected, and a long term investor, I'm low on my hundred dollar target...
your anger is understandable. China's lack of economic recovery is a killer. No one thought it would last this long, and shows no sign of ending. things will stink till then.